Sofwave Medical to Participate in Wells Fargo Healthcare Conference

SAN CLEMENTE, Calif., Sept. 01, 2026 /CourierPR/ -- Sofwave Medical Ltd., a global leader in energy-based non-invasive aesthetic medical devices, will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference from September 8 to 10, 2026. CEO Louis Scafuri and Chief Financial Officer Assaf Korner will represent the company at the event.

Sofwave Medical, listed on the Tel Aviv Stock Exchange under the symbol SOFW, specializes in advancing non-invasive technologies for skin and body regeneration. The company’s flagship technology, SUPERB™, delivers controlled ultrasound energy to the mid-dermis to stimulate the body’s natural regenerative response. This technology is FDA-cleared for treating facial lines and wrinkles, lifting eyebrows, and lax submental and neck tissue. It also improves the appearance of skin laxity on the upper arms, offers a short-term improvement in the appearance of cellulite, and treats acne scars.

In addition to SUPERB™, Sofwave’s portfolio includes Pure Impact™, which uses electrical muscle stimulation (EMS) technology for muscle strengthening, toning, and firming. These technologies provide physicians with clinically supported, non-invasive solutions for the evolving needs of aesthetic patients worldwide.

The company’s innovations have positioned it as a key player in the global regenerative aesthetics market. SUPERB™ and Pure Impact™ are part of its comprehensive suite of products designed to meet the diverse needs of healthcare practitioners and their clients.